MABWELL ANNOUNCES ACCEPTANCE OF SUPPLEMENTAL BIOLOGICS LICENSE APPLICATION BY NMPA FOR MAIWEIJIAN (DENOSUMAB)

Reuters · 2d ago

Please log in to view news